Gilead Sciences(NASDAQ:GILD)announces that the FDA has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials in all ongoing clinical studies for HIV treatment and HIV pre-...
网页链接Gilead Sciences(NASDAQ:GILD)announces that the FDA has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials in all ongoing clinical studies for HIV treatment and HIV pre-...
网页链接
精彩评论